India's Jubilant Organosys has made good on promises to make
acquisitions in the contract research and manufacturing services
(CRAMS) sector with a $255m deal to buy Draxis Health of Canada.
India's Jubilant Organosys has bought two companies in Belgium as
part of a drive to improve its presence in the European market for
generic drugs and active pharmaceutical ingredients (APIs).